Garches
Garches
Garches, Île-de-France Region, France2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy | Hemic and Lymphatic Diseases, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, blood coagulation disease, cardiovascular disorder, disseminated intravascular coagulation, hematologic disorder, hemorrhagic disease, thrombophilia, vascular disorder, vascular hemostatic disease | Recruiting | Phase 1 | 2026-09-23 | NCT06854640 | |
| Modifying Factors in Striated Muscle Laminopathies | Autosomal Emery-Dreifuss Muscular Dystrophy, Cardiomegaly, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Emery-Dreifuss muscular dystrophy, Muscular Disorders, Atrophic, autosomal dominant Emery-Dreifuss muscular dystrophy, cardiomyopathy, cardiovascular disorder, congenital muscular dystrophy due to LMNA mutation, dilated cardiomyopathy, heart disorder, hereditary disease, laminopathy, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Recruiting | Not applicable | 2026-03-04 | NCT05394506 |